Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Br J Psychiatry. 2022 Jul 1;221(1):425–427. doi: 10.1192/bjp.2022.42

Fig. 1.

Fig. 1

(A) Kaplan-Meier curves for the primary analysis showing the cumulative incidence of confirmed COVID-19 diagnoses or positive PCR test for SARS-CoV-2 after a therapeutic (red) vs. subtherapeutic (blue) lithium level in matched cohorts. The shaded areas around the curves [see pdf version of figure below] represent 95% confidence intervals. (B) Hazard ratios for the comparison between matched cohorts in the secondary and robustness analyses. *p<0.05, **p<0.01.